203 related articles for article (PubMed ID: 15654766)
1. Extracellular RNA is a natural cofactor for the (auto-)activation of Factor VII-activating protease (FSAP).
Nakazawa F; Kannemeier C; Shibamiya A; Song Y; Tzima E; Schubert U; Koyama T; Niepmann M; Trusheim H; Engelmann B; Preissner KT
Biochem J; 2005 Feb; 385(Pt 3):831-8. PubMed ID: 15654766
[TBL] [Abstract][Full Text] [Related]
2. Nucleic acids potentiate Factor VII-activating protease (FSAP)-mediated cleavage of platelet-derived growth factor-BB and inhibition of vascular smooth muscle cell proliferation.
Shibamiya A; Muhl L; Tannert-Otto S; Preissner KT; Kanse SM
Biochem J; 2007 May; 404(1):45-50. PubMed ID: 17300216
[TBL] [Abstract][Full Text] [Related]
3. Factor VII and single-chain plasminogen activator-activating protease: activation and autoactivation of the proenzyme.
Kannemeier C; Feussner A; Stöhr HA; Weisse J; Preissner KT; Römisch J
Eur J Biochem; 2001 Jul; 268(13):3789-96. PubMed ID: 11432747
[TBL] [Abstract][Full Text] [Related]
4. Factor VII activating protease (FSAP): a novel protease in hemostasis.
Römisch J
Biol Chem; 2002; 383(7-8):1119-24. PubMed ID: 12437095
[TBL] [Abstract][Full Text] [Related]
5. High negative charge-to-size ratio in polyphosphates and heparin regulates factor VII-activating protease.
Muhl L; Galuska SP; Oörni K; Hernández-Ruiz L; Andrei-Selmer LC; Geyer R; Preissner KT; Ruiz FA; Kovanen PT; Kanse SM
FEBS J; 2009 Sep; 276(17):4828-39. PubMed ID: 19664058
[TBL] [Abstract][Full Text] [Related]
6. A positively charged cluster in the epidermal growth factor-like domain of Factor VII-activating protease (FSAP) is essential for polyanion binding.
Altincicek B; Shibamiya A; Trusheim H; Tzima E; Niepmann M; Linder D; Preissner KT; Kanse SM
Biochem J; 2006 Mar; 394(Pt 3):687-92. PubMed ID: 16332249
[TBL] [Abstract][Full Text] [Related]
7. Structure-function analysis of factor VII activating protease (FSAP): sequence determinants for heparin binding and cellular functions.
Muhl L; Hersemeyer K; Preissner KT; Weimer T; Kanse SM
FEBS Lett; 2009 Jun; 583(12):1994-8. PubMed ID: 19446554
[TBL] [Abstract][Full Text] [Related]
8. Factor VII-activating protease in patients with acute deep venous thrombosis.
Sidelmann JJ; Vitzthum F; Funding E; Münster AM; Gram J; Jespersen J
Thromb Res; 2008; 122(6):848-53. PubMed ID: 18394684
[TBL] [Abstract][Full Text] [Related]
9. Factor VII-activating protease is activated in multiple trauma patients and generates anaphylatoxin C5a.
Kanse SM; Gallenmueller A; Zeerleder S; Stephan F; Rannou O; Denk S; Etscheid M; Lochnit G; Krueger M; Huber-Lang M
J Immunol; 2012 Mar; 188(6):2858-65. PubMed ID: 22308306
[TBL] [Abstract][Full Text] [Related]
10. Nucleosome-releasing factor: a new role for factor VII-activating protease (FSAP).
Zeerleder S; Zwart B; te Velthuis H; Stephan F; Manoe R; Rensink I; Aarden LA
FASEB J; 2008 Dec; 22(12):4077-84. PubMed ID: 18753248
[TBL] [Abstract][Full Text] [Related]
11. Plasminogen activator inhibitor-1 is an inhibitor of factor VII-activating protease in patients with acute respiratory distress syndrome.
Wygrecka M; Morty RE; Markart P; Kanse SM; Andreasen PA; Wind T; Guenther A; Preissner KT
J Biol Chem; 2007 Jul; 282(30):21671-82. PubMed ID: 17540775
[TBL] [Abstract][Full Text] [Related]
12. FSAP, a new player in inflammation?
Stephan F; Aarden LA; Zeerleder S
Hamostaseologie; 2012; 32(1):51-5. PubMed ID: 22252569
[TBL] [Abstract][Full Text] [Related]
13. Factor seven activating protease (FSAP): does it activate factor VII?
Stavenuiter F; Dienava-Verdoold I; Boon-Spijker MG; Brinkman HJ; Meijer AB; Mertens K
J Thromb Haemost; 2012 May; 10(5):859-66. PubMed ID: 22235940
[TBL] [Abstract][Full Text] [Related]
14. Raised protein levels and altered cellular expression of factor VII activating protease (FSAP) in the lungs of patients with acute respiratory distress syndrome (ARDS).
Wygrecka M; Markart P; Fink L; Guenther A; Preissner KT
Thorax; 2007 Oct; 62(10):880-8. PubMed ID: 17483138
[TBL] [Abstract][Full Text] [Related]
15. The frequent Marburg I polymorphism impairs the pro-urokinase activating potency of the factor VII activating protease (FSAP).
Roemisch J; Feussner A; Nerlich C; Stoehr HA; Weimer T
Blood Coagul Fibrinolysis; 2002 Jul; 13(5):433-41. PubMed ID: 12138371
[TBL] [Abstract][Full Text] [Related]
16. The Marburg I polymorphism of factor VII activating protease is associated with low proteolytic and low pro-coagulant activity.
Etscheid M; Muhl L; Pons D; Jukema JW; König H; Kanse SM
Thromb Res; 2012 Dec; 130(6):935-41. PubMed ID: 22906531
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the substrate specificity of Factor VII activating protease (FSAP) and design of specific and sensitive peptide substrates.
Kara E; Manna D; Løset GÅ; Schneider EL; Craik CS; Kanse S
Thromb Haemost; 2017 Aug; 117(9):1750-1760. PubMed ID: 28726978
[TBL] [Abstract][Full Text] [Related]
18. Factor VII activating protease. Single nucleotide polymorphisms light the way.
Kanse SM; Etscheid M
Hamostaseologie; 2011 Aug; 31(3):174-6, 177-8. PubMed ID: 21655671
[TBL] [Abstract][Full Text] [Related]
19. Factor VII-activating protease (FSAP): vascular functions and role in atherosclerosis.
Kanse SM; Parahuleva M; Muhl L; Kemkes-Matthes B; Sedding D; Preissner KT
Thromb Haemost; 2008 Feb; 99(2):286-9. PubMed ID: 18278176
[TBL] [Abstract][Full Text] [Related]
20. The G534E polymorphism of the gene encoding the factor VII-activating protease is associated with cardiovascular risk due to increased neointima formation.
Sedding D; Daniel JM; Muhl L; Hersemeyer K; Brunsch H; Kemkes-Matthes B; Braun-Dullaeus RC; Tillmanns H; Weimer T; Preissner KT; Kanse SM
J Exp Med; 2006 Dec; 203(13):2801-7. PubMed ID: 17145954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
